ArticleiScience2024
PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer.
Wenhan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleiScience2024
Wenhan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.